Vaccination-induced functional competence of circulating human tumor-specific CD8 T-cells-Reference-Cited by-同舟云学术

Vaccination-induced functional competence of circulating human tumor-specific CD8 T-cells

Published:2011-08-24 Issue:11 Volume:130 Page:2607-2617
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Baumgaertner Petra,Jandus Camilla,Rivals Jean-Paul,Derré Laurent,Lövgren Tanja,Baitsch Lukas,Guillaume Philippe,Luescher Immanuel F.,Berthod Gregoire,Matter Maurice,Rufer Nathalie,Michielin Olivier,Speiser Daniel E.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference50 articles.

1. Discrepancy between in vitro measurable and in vivo virus neutralizing cytotoxic T cell reactivities: low T cell receptor specificity and avidity sufficient for in vitro proliferation or cytotoxicity to peptide coated target cells but not for in vivo protection;Speiser;J Immunol,1992

2. Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy;Alexander-Miller;Proc Natl Acad Sci USA,1996

3. Direct link between MHC polymorphism, T cell avidity, and diversity in immune defense;Messaoudi;Science,2002

4. Endogenous naive CD8+ T cell precursor frequency regulates primary and memory responses to infection;Obar;Immunity,2008

5. Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude;Moon;Immunity,2007

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mutant and non-mutant neoantigen-based cancer vaccines: recent advances and future promises;Exploration of Targeted Anti-tumor Therapy;2022-12-22

2. The tissue-resident marker CD103 on peripheral blood T cells predicts responses to anti-PD-1 therapy in gastric cancer;Cancer Immunology, Immunotherapy;2022-07-01

3. Fueling Cancer Vaccines to Improve T Cell-Mediated Antitumor Immunity;Frontiers in Oncology;2022-05-16

4. Helicase antigen (HAGE)‐derived vaccines induce immunity to HAGE and ImmunoBody®‐HAGE DNA vaccine delays the growth and metastasis of HAGE‐expressing tumors in vivo;Immunology & Cell Biology;2021-09-19

5. Defective Natural Killer Cells in Melanoma: Role of NKG2D in Pathogenesis and Immunotherapy;Critical Reviews in Immunology;2021